Brief: Transgene And Hypertrust Patient Data Care Announce Blockchain Solution For Clinical Trials Of Personalized Healthcare
July 9 (Reuters) - TRANSGENE SA TRNG.PA :
* TRANSGENE AND HYPERTRUST PATIENT DATA CARE ANNOUNCE
SUCCESSFUL
GO-LIVE OF THE WORLD’S FIRST BLOCKCHAIN SOLUTION FOR CLINICAL
TRIALS OF PERSONALIZED HEALTHCARE
* CLOUD-BASED SOLUTION MONITORS AND ORCHESTRATES SUPPLY
CHAIN
PROCESSES OF TRANSGENE'S AI-ENHANCED TG4050 INDIVIDUALIZED
THERAPEUTIC VACCINE
Source text for Eikon: ID:nNDL4tqqn7
Further company coverage: TRNG.PA
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Transgene SA
See all newsFrance's Transgene H1 operating income falls on lower tax credit
Transgene jumps 20% on positive cancer vaccine data in early trial
Brief: Transgene & NEC Bio Sign License Agreement To Prepare Next Steps Of Development Of TG4050 In Head & Neck Cancer
Brief: Transgene SA Says Myvac Platform To Initiate Phase 1 Trial In Second Indication In 2026
France's Transgene 2025 net loss widens on higher financial costs